Literature DB >> 15167402

Antiretroviral adherence in persons with HIV/AIDS and severe mental illness.

Jeanne K Kemppainen1, Roger Levine, Marti Buffum, William Holzemer, Patrick Finley, Peter Jensen.   

Abstract

This study identified factors impacting adherence to human immunodeficiency virus (HIV) therapies in a sample of 46 persons diagnosed with HIV/acquired immune deficiency syndrome and severe mental illness who were receiving care through a day care program in Northern California. Comprehensive descriptions of factors and circumstances that influence adherence behaviors were obtained through critical incident interviews, and a taxonomy of adherence factors was determined. A chi2 analysis that examined differences between patient characteristics and major adherence factors found that planning was more likely to be reported by older persons taking HIV medications over longer periods. Nonwhite persons and those living alone were more apt to rely on the use of reminders and cues. Persons with bipolar disorder reported substantially more incidents of the impact of their symptoms on adherence to HIV therapies than persons with other psychiatric diagnoses. The taxonomy of adherence factors provides important information for developing relevant adherence education programs and an essential foundation for testing compliance interventions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167402     DOI: 10.1097/01.nmd.0000130132.55146.04

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  7 in total

1.  HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.

Authors:  David J Moore; Carolina Posada; Mili Parikh; Miguel Arce; Florin Vaida; Patricia K Riggs; Ben Gouaux; Ronald J Ellis; Scott L Letendre; Igor Grant; J Hampton Atkinson
Journal:  AIDS Behav       Date:  2012-11

2.  Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective.

Authors:  Michael K Paasche-Orlow; Debbie M Cheng; Anita Palepu; Seville Meli; Vincent Faber; Jeffrey H Samet
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

3.  Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach.

Authors:  Brandon A Gaudiano; Lauren M Weinstock; Ivan W Miller
Journal:  J Psychiatr Pract       Date:  2011-01       Impact factor: 1.325

4.  Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.

Authors:  Jayraan Badiee; Patricia K Riggs; Alexandra S Rooney; Florin Vaida; Igor Grant; J Hampton Atkinson; David J Moore
Journal:  AIDS Patient Care STDS       Date:  2012-06-11       Impact factor: 5.078

Review 5.  A new taxonomy for describing and defining adherence to medications.

Authors:  Bernard Vrijens; Sabina De Geest; Dyfrig A Hughes; Kardas Przemyslaw; Jenny Demonceau; Todd Ruppar; Fabienne Dobbels; Emily Fargher; Valerie Morrison; Pawel Lewek; Michal Matyjaszczyk; Comfort Mshelia; Wendy Clyne; Jeffrey K Aronson; J Urquhart
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 6.  Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.

Authors:  Edward J Mills; Jean B Nachega; David R Bangsberg; Sonal Singh; Beth Rachlis; Ping Wu; Kumanan Wilson; Iain Buchan; Christopher J Gill; Curtis Cooper
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

7.  Psychopathological Dimensions in Substance Abusers with and without HIV/AIDS and Healthy Matched Group.

Authors:  Sajjad Rezaei; Sonbol Taramian; Seyed Mousa Kafie
Journal:  Addict Health       Date:  2013 Summer-Autumn
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.